ODTX (Odyssey Therapeutics) PS Ratio: (As of Jun. 30, 2026)


ODTX Odyssey Therapeutics Inc ODTX
9 GF Score
Price $19.25
! 2 Warning Signs
View Full Analysis

What is Odyssey Therapeutics PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Odyssey Therapeutics's share price is $19.25. Odyssey Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Hence, Odyssey Therapeutics's PS Ratio for today is .

The historical rank and industry rank for Odyssey Therapeutics's PS Ratio or its related term are showing as below:

ODTX' s PS Ratio Range Over the Past 10 Years
Min: 174.72   Med: 250   Max: 272.43
Current: 178.23

During the past 4 years, Odyssey Therapeutics's highest PS Ratio was 272.43. The lowest was 174.72. And the median was 250.00.

ODTX's PS Ratio is ranked worse than
88.34% of 935 companies
in the Biotechnology industry
Industry Median: 9.37 vs ODTX: 178.23

Odyssey Therapeutics's Revenue per Sharefor the three months ended in Mar. 2026 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Warning Sign:

Odyssey Therapeutics Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Odyssey Therapeutics was -33.30% per year.

Back to Basics: PS Ratio


Odyssey Therapeutics  (NAS:ODTX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Odyssey Therapeutics PS Ratio Related Terms


Odyssey Therapeutics PS Ratio Historical Data

* Premium members only.

The historical data trend for Odyssey Therapeutics's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Therapeutics PS Ratio Chart

Odyssey Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
PS Ratio
0.00 0.00 0.00 0.00

Odyssey Therapeutics Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ODTX vs VOR, PHAT, GERN: PS Ratio Comparison

For the Biotechnology subindustry, Odyssey Therapeutics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Therapeutics PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Odyssey Therapeutics's PS Ratio distribution charts can be found below:

* The bar in red indicates where Odyssey Therapeutics's PS Ratio falls into.


ODTX
9GF Score
Odyssey Therapeutics Inc ODTX
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Odyssey Therapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Odyssey Therapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=19.25/0
=

Odyssey Therapeutics's Share Price of today is $19.25.
Odyssey Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Odyssey Therapeutics Business Description

Address 51 Sleeper Street, Boston, MA, USA, 02210
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
9GF Score

Get the complete analysis for ODTX

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price